{"abstract": "Diabetes drug developer Metabolex parlayed a strong partnership with Johnson & Johnson and promising early clinical data on its lead compound into a $32 million Series D round of venture capital from crossover investors, which could position the company for a public offering as soon as next year.", "web_url": "https://dealbook.nytimes.com/2007/04/20/metabolex-pumps-vcs-for-32-million/", "snippet": "", "lead_paragraph": "Diabetes drug developer Metabolex parlayed a strong partnership with Johnson & Johnson and promising early clinical data on its lead compound into a $32 million Series D round of venture capital from crossover investors, which could position the company for a public offering as soon as next year.", "source": "The New York Times", "multimedia": [], "headline": {"main": "Metabolex Pumps V.C.s for $32 Million", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [], "pub_date": "2007-04-20T11:14:32+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Dealbook", "person": [{"firstname": "Dealbook", "middlename": null, "lastname": "", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/69b2c84a-6e61-5ad5-aaea-2007219eba2f", "word_count": 86, "uri": "nyt://article/69b2c84a-6e61-5ad5-aaea-2007219eba2f"}